Connecting investors and companies

Solwers' Q1 was weaker than our expectations, and the income lines, which are important for deleveraging, remained slightly below even the weak comparison period.

9:07

Harvia's Q1 earnings exceeded our estimates, but the estimate changes for the full year remained small.

Bioretec's start to the year offered a positive surprise.

We cut our estimates, especially for the current year, in the wake of the profit warning issued by the company before the earnings release.

Attention should next turn to the Capital Markets Day, which will take place in just over a week, when the company will unveil its updated strategy.

17:53

Geopolitical tensions were reflected in weak room demand in Gibraltar, but on a positive note, sales in London developed strongly and relative profitability remained at the previous year’s level.

We have updated our target price for Mandatum to account for the dividend payout. Our estimates and view of the company remain unchanged.

14:46

Relais is entering a new era driven by a renewed strategy focused not only on growth, but also on delivering stronger returns.

The 5 MEUR financing supports the growth strategy.

Relais' Q1 figures surpassed our estimates by a wide margin, as organic growth was stronger than anticipated.

The main phases of strategy implementation are: 2026 – Renew, 2027 – Grow, 2028 – Scale.

Multitude's Q1 earnings missed our estimates, though the company reiterated its full-year guidance.

11:32

Kalmar's Q1 figures were generally below our expectations.

Despite the strong growth outlook, we still consider the stock highly priced.

The target company is highly profitable and will increase GRK's share of private sector customers, thereby reducing its dependence on public projects.

Short-term earnings improvement hinges on Dollarstore’s turnaround.